Ranjbar Mitra, Karbalaie Niya Mohammad Hadi, Roham Maryam, Rezaie Nader, Yadollahzadeh Mahdi, Farrokhpour Mohsen, Azimi Mehdi, Motamed Nima, Perumal Dhayaneethie, Tameshkel Fahimeh Safarnezhad, Dadras Farahnaz, Madani Nahid Hashemi, Ghanbari Behrooz, Faraji Amirhossein, Nikkhah Mehdi, Rahmani Shahrzad, Golgiri Fatemah, Emadi Seyed Yadollah, Abbasi Rowshanak, Mohseni Iman, Babaei Mohammad Reza, Eskandari Ramin, Ataee Manizhe, Panahi Mahshid, Zamani Farhad, Makiani Mahin Jamshidi, Laali Azadeh
Department of Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.
Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.
J Res Med Sci. 2021 Nov 29;26:112. doi: 10.4103/jrms.JRMS_1151_20. eCollection 2021.
Due to widespread of coronavirus disease 2019 (COVID-19) infection, identification of its risk factors and clinical characteristics are important. The aim of the present study was to assess Vitamin D levels in individuals with severe acute respiratory syndrome coronavirus-19 infection and to report on its potential as a predictive marker.
All patients, diagnosed with COVID-19 infection from February 16 to March 21, 2020, and referred to Firoozgar Hospital, Tehran, Iran, were enrolled in this study. Vitamin D analysis was undertaken on patient serum samples using a commercial kit (Pars Azmoon Co., Tehran, Iran). SPSS v. 22 was used for statistical analysis.
Vitamin D serum concentration was analyzed in a total of 317 patients whose mean age ± standard deviation was 62.05 ± 15 years and with 62.5% being male. A significant association of Vitamin D level and death was observed. Higher levels of serum Vitamin D had protection against death (odds ratio = 0.955 [95% confidence interval = 0.923-0.988], = 0.008).
As a preliminary study in the Iranian population who suffered COVID-19 disease, we identified that Vitamin D deficiency was associated with a higher death rate and intensive care unit admission.
由于2019冠状病毒病(COVID-19)感染广泛传播,识别其危险因素和临床特征很重要。本研究的目的是评估严重急性呼吸综合征冠状病毒2感染患者的维生素D水平,并报告其作为预测标志物的潜力。
本研究纳入了2020年2月16日至3月21日期间在伊朗德黑兰菲罗兹加尔医院被诊断为COVID-19感染的所有患者。使用商用试剂盒(伊朗德黑兰Pars Azmoon公司)对患者血清样本进行维生素D分析。采用SPSS v. 22进行统计分析。
共分析了317例患者的维生素D血清浓度,其平均年龄±标准差为62.05±15岁,男性占62.5%。观察到维生素D水平与死亡之间存在显著关联。较高的血清维生素D水平对死亡有保护作用(比值比=0.955[95%置信区间=0.923-0.988],P=0.008)。
作为对感染COVID-19疾病的伊朗人群的初步研究,我们发现维生素D缺乏与较高的死亡率和重症监护病房入院率相关。